Earnings

Comparing Top Moving Stocks Realogy Holdings Corp. (RLGY), Biocept, Inc. (BIOC)

The shares of Realogy Holdings Corp. have decreased by more than -8.38% this year alone. The shares recently went down by -2.10% or -$0.52 and now trades at $24.28. The shares of Biocept, Inc. (NASDAQ:BIOC), has slumped by -68.30% year to date as of 05/15/2018. The shares currently trade at $0.22 and have been able to report a change of 1.95% over the past one week.

The stock of Realogy Holdings Corp. and Biocept, Inc. were two of the most active stocks on Tueday. Investors seem to be very interested in what happens to the stocks of these two companies but do investors favor one over the other? We will analyze the growth, profitability, risk, valuation, and insider trends of both companies and see which one investors prefer.

Next 5Y EPS Growth: 10.70% versus 40.00%

When a company is able to grow consistently in terms of earnings at a high compound rate have the highest likelihood of creating value for its shareholders over time. Analysts have predicted that RLGY will grow it’s earning at a 10.70% annual rate in the next 5 years. This is in contrast to BIOC which will have a positive growth at a 40.00% annual rate. This means that the higher growth rate of BIOC implies a greater potential for capital appreciation over the years.

Profitability and Returns

Growth alone cannot be used to see if the company will be valuable. Shareholders will be the losers if a company invest in ventures that aren’t profitable enough to support upbeat growth. In order for us to accurately measure profitability and return, we will be using the EBITDA margin and Return on Investment (ROI), which balances the difference in capital structure. RLGY has an EBITDA margin of 10.86%, this implies that the underlying business of RLGY is more profitable. The ROI of RLGY is 6.90% while that of BIOC is -452.70%. These figures suggest that RLGY ventures generate a higher ROI than that of BIOC.

Cash Flow



The value of a stock is ultimately determined by the amount of cash flow that the investors have available. Over the last 12 months, RLGY’s free cash flow per share is a negative -2.67, while that of BIOC is also a negative -0.25.

Liquidity and Financial Risk

The ability of a company to meet up with its short-term obligations and be able to clear its longer-term debts is measured using Liquidity and leverage ratios. The current ratio for RLGY is 0.70 and that of BIOC is 0.90. This implies that it is easier for RLGY to cover its immediate obligations over the next 12 months than BIOC. The debt ratio of RLGY is 1.56 compared to 2.15 for BIOC. BIOC can be able to settle its long-term debts and thus is a lower financial risk than RLGY.

Valuation

RLGY currently trades at a forward P/E of 10.75, a P/B of 1.30, and a P/S of 0.50 while BIOC trades at a P/B of 5.50, and a P/S of 2.88. This means that looking at the earnings, book values and sales basis, RLGY is the cheaper one. It is very obvious that earnings are the most important factors to investors, thus analysts are most likely to place their bet on the P/E.

Analyst Price Targets and Opinions




The mistake some people make is that they think a cheap stock has more value to it. In order to know the value of a stock, there is need to compare its current price to its likely trading price in the future. The price of RLGY is currently at a -21.95% to its one-year price target of 31.11.

When looking at the investment recommendation on say a scale of 1 to 5 (1 being a strong buy, 3 a hold, and 5 a sell), RLGY is given a 2.20 while 2.00 placed for BIOC. This means that analysts are more bullish on the outlook for RLGY stocks.

Insider Activity and Investor Sentiment

Short interest or otherwise called the percentage of a stock’s tradable shares currently being shorted is another data that investors use to get a handle on sentiment. The short ratio for RLGY is 9.54 while that of BIOC is just 2.57. This means that analysts are more bullish on the forecast for BIOC stock.

Conclusion

The stock of Realogy Holdings Corp. defeats that of Biocept, Inc. when the two are compared, with RLGY taking 6 out of the total factors that were been considered. RLGY happens to be more profitable, generates a higher ROI, has higher cash flow per share, higher liquidity and has a lower financial risk. When looking at the stock valuation, RLGY is the cheaper one on an earnings, book value and sales basis. Finally, the sentiment signal for RLGY is better on when it is viewed on short interest.

Previous ArticleNext Article

Related Post

Taking Tally Of Pfizer Inc. (PFE), International B... The shares of Pfizer Inc. have increased by more than 0.30% this year alone. The shares recently went up by 0.14% or $0.05 and now trades at $36.33. T...
Taking Tally Of Sesen Bio, Inc. (SESN), Nektar The... The shares of Sesen Bio, Inc. have increased by more than 210.73% this year alone. The shares recently went up by 11.01% or $0.25 and now trades at $2...
Set Sail With International Game Technology PLC (I... The shares of International Game Technology PLC have decreased by more than -7.28% this year alone. The shares recently went down by -0.69% or -$0.17 ...
Tailored Brands, Inc. (TLRD) vs. Francesca’s... Tailored Brands, Inc. (NYSE:TLRD) shares are down more than -21.64% this year and recently decreased -2.15% or -$0.44 to settle at $20.02. Francesca's...
Set Sail With Targa Resources Corp. (TRGP), Plains... The shares of Targa Resources Corp. have increased by more than 1.84% this year alone. The shares recently went down by -0.82% or -$0.41 and now trade...